Clinical Trial Update: A Trial to Assess the Safety, Tolerability, and Pharmacokinetics of the Anti-Orthopoxvirus Compound Tecovirimat [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update evaluating safety, tolerability, and pharmacokinetics of tecovirimat (TPOXX) for smallpox; the study completed and results were po…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Smallpox

Drugs mentioned

• Tpoxx (tecovirimat) (tecovirimat)

Snippet

Sponsor: SIGA Technologies | Conditions: Smallpox | Phase 3 | Status: COMPLETED | Results posted: 2017-11-28